ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)
NCT06487585
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Vasodilatory Hypotension During or After Cardiac Surgery
Interventions
DRUG:
Angiotensin II
Sponsor
University of Maryland St. Joseph Medical Center
Collaborators
[object Object]